Reporting Manager
Forbion Growth Opportunities Fund II Cooperatief U.A.
Symbol
BCYC
Shares outstanding
47,292,192 shares
Disclosed Ownership
3,452,330 shares
Ownership
7.3%
Form type
SCHEDULE 13G
Filing time
19 Dec 2024, 15:47:50 UTC
Date of event
21 Nov 2024

Sponsored

Quoteable Key Fact

"Forbion Growth Opportunities Fund II Cooperatief U.A. disclosed 7.3% ownership in Bicycle Therapeutics plc Ordinary shares, nominal value 0.01 per share (BCYC) on 21 Nov 2024."

Quick Takeaways

  • Forbion Growth Opportunities Fund II Cooperatief U.A. filed SCHEDULE 13G for Bicycle Therapeutics plc Ordinary shares, nominal value 0.01 per share (BCYC).
  • Disclosed ownership: 7.3%.
  • Date of event: 21 Nov 2024.

What Changed

  • No earlier schedule filing is available for direct comparison.
  • Current filing was accepted on 19 Dec 2024, 15:47.

Why This Matters

  • This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
  • You can verify ownership claims directly against the original SEC filing.

Source Evidence

Backed by Schedule 13D/13G

Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.

See Original Filing

Reporting Managers (2)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
Forbion Growth Opportunities Fund II Cooperatief U.A. 7.3% 3,452,330 0 3,452,330 /s/ V. van Houten and /s/ G.J. Mulder V. van Houten and G.J. Mulder, Dirs. of FCPM III Svcs B.V., Dir. of Forbion Growth II Mngmt B.V., Dir. of Forbion Growth Opps Fund II Cooperatief U.A.
FORBION GROWTH II MANAGEMENT B.V. 7.3% 3,452,330 0 3,452,330 /s/ V. van Houten and /s/ G.J. Mulder V. van Houten and G.J. Mulder, Directors of FCPM III Services B.V., Director of Forbion Growth II Management B.V.